Free Breath, Free Life!
AeproMED revolutionizes healthcare with personalized medicine through state-of-the-art aerosol technology and integrated bio-signal detection.
AIRHYPER Platform (AHP)
Seamless Transition from Animal to Human Models
More efficient inhaled medicine to your lung.
Auto-record actionable data feedback to patients, clinicians.
Digital monitor to deliver medicine with patient’s breath pattern.
Advantages of Techniques
Aerosol Variable-frequency Transport Technology (AVTT)
Our technology could shorten the time of inhaling the medicine, improving drug delivery efficiency even to different features of medicine. We consider illness patients suffering from breathing issues, optimized delivery performance with the patient’s breathing pattern.
Shorten time
Auto-optimized to easy use
Consideration design with
patient’s breath pattern
Stakeholders
Patients
Patients
Clinicians /Hospital
Clinicians /Hospital
Pharma
Pharma
Investors
Investors
News&Insights
【2024 CES., Consumer Electronics Show in Las Vegas】
AeproMED will launch its 2024 journey at the CES Exhibition, with a focus on the fields of sub-healthcare and medical co
【Inhaled Medications for Systemic Treatment: Unlocking the Potential of Pulmonary Drug Delivery】
Did you know that inhaled drug delivery has emerged as a promising avenue for systemic treatment? Leveraging the expansi
【The 20th National Innovation Award】
The 20th National Innovation Award ceremony took place at the end of 2023. In front of a distinguished audience of 1200
【2024 CES., Consumer Electronics Show in Las Vegas】
AeproMED will launch its 2024 journey at the CES Exhibition, with
【Inhaled Medications for Systemic Treatment: Unlocking the Potential of Pulmonary Drug Delivery】
Did you know that inhaled drug delivery has emerged as a promisin
【The 20th National Innovation Award】
The 20th National Innovation Award ceremony took place at the end
Contact us
We‘d love to tell you more about AeproMED…
